91 related articles for article (PubMed ID: 28542986)
1. Tryptase expression as a prognostic marker in patients with resected gastric cancer.
Lin C; Liu H; Zhang H; Cao Y; Li R; Wu S; Li H; He H; Xu J; Sun Y
Br J Surg; 2017 Jul; 104(8):1037-1044. PubMed ID: 28542986
[TBL] [Abstract][Full Text] [Related]
2. Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery.
Ammendola M; Sacco R; Zuccalà V; Luposella M; Patruno R; Gadaleta P; Zizzo N; Gadaleta CD; De Sarro G; Sammarco G; Oltean M; Ranieri G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854307
[TBL] [Abstract][Full Text] [Related]
3. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
4. Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor.
Alì G; Boldrini L; Lucchi M; Mussi A; Corsi V; Fontanini G
J Thorac Oncol; 2009 Mar; 4(3):348-54. PubMed ID: 19155997
[TBL] [Abstract][Full Text] [Related]
5. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
[TBL] [Abstract][Full Text] [Related]
6. Correlations Between the Density of Tryptase Positive Mast Cells (DMCT) and that of New Blood Vessels (CD105+) in Patients with Gastric Cancer.
Micu GV; Stăniceanu F; Sticlaru LC; Popp CG; Bastian AE; Gramada E; Pop G; Mateescu RB; Rimbaş M; Archip B; Bleotu C
Rom J Intern Med; 2016; 54(2):113-20. PubMed ID: 27352440
[TBL] [Abstract][Full Text] [Related]
7. Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically.
Ammendola M; Sacco R; Donato G; Zuccalà V; Russo E; Luposella M; Vescio G; Rizzuto A; Patruno R; De Sarro G; Montemurro S; Sammarco G; Ranieri G
Oncology; 2013; 85(2):111-6. PubMed ID: 23887206
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.
Lin C; Liu H; Zhang H; He H; Li H; Shen Z; Qin J; Qin X; Xu J; Sun Y
Oncotarget; 2016 Aug; 7(31):49281-49288. PubMed ID: 27351230
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
10. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.
Wang Z; Liu H; Shen Z; Wang X; Zhang H; Qin J; Xu J; Sun Y; Qin X
BMC Cancer; 2015 Oct; 15():766. PubMed ID: 26497045
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
13. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
14. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating tryptase
Hu G; Wang S; Cheng P
Int J Cancer; 2018 Feb; 142(4):813-821. PubMed ID: 29023696
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of noggin protein expression in patients with resected gastric cancer.
Chun SH; Kim EY; Yoon JS; Won HS; Yim K; Hwang HW; Hong SA; Lee M; Lee SL; Kim SS; Sun S; Ko YH
BMC Cancer; 2021 May; 21(1):558. PubMed ID: 34001012
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
19. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T
Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
